PARIS — Laurent Attal, executive vice president of Research and Innovation at L’Oréal, will replace the company’s honorary chairman Lindsay Owen-Jones as a Sanofi board director.
Owen-Jones informed Sanofi’s board of directors that he was not seeking reappointment when his term expires on May 4, the company said in a statement today.
“I would like to express my sincere gratitude to Sir Lindsay Owen-Jones for his strong contribution as a board member over the last 13 years,” stated Serge Weinberg, chairman of Sanofi’s board of directors. “The vision and experience of such a renowned international leader have been invaluable assets for the governance of the group and the development of Sanofi during this period.”
L’Oréal has long held a stake in Sanofi. By year-end 2011, the French beauty giant owned 8.8 percent of Sanofi’s shares and commanded 15.7 percent of its voting rights.